Antitrust Antitrust

Comment: EU merger reviews continue but will be hampered by Covid-19 crisis

By Natalie McNelis and Nicholas Hirst
  • 27 Mar 2020 09:55
  • 27 Mar 2020 09:55

Dealmakers had some cause for cheer from the EU merger regulator this week, as it made clear it would continue to review the bulk of transactions knocking at its door.

The decision to open an in-depth review into Johnson & Johnson’s purchase of TachoSil (see here) is the latest sign that,

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News